Global Constipation Market Report: 2016 Edition – New Report by Koncept Analytics

The report, “Global Constipation Market” analyzes the currently prevailing condition of the market along with its future scope of development.

Constipation is a common medical condition common among elderly and women, and is interpreted differently by patients and physicians. Constipation can be chronic, sometimes severe, and has a significant, even deliberating effect on the quality of life of a patient. Various treatment options are available for the treatment of constipation and patients often adopt different over-the-counter remedies for the same. There exist three main types of constipation including Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome (IBS-C) and Opioid Induced Constipation (OIC).

There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.

Growth of the constipation market is driven by several factors including rising prescription opioid consumption, growing ageing population, vast opportunity for drugs with significant potential in the U.S., rising spending on medicines, growing female population and rising healthcare expenditure. However, the growth of the market can be hindered by certain challenges including rising tide of OTC drugs for constipation and lower awareness of prescription medication for OIC.

The report, “Global Constipation Market” analyzes the currently prevailing condition of the market along with its future scope of development. The specific markets of the U.S. Japan China and Europe are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.

List of Charts

The U.S. Constipation Market by Value (2011-2014)
The U.S. Constipation Market Value by Type (2011-2014)
The U.S. Constipation Market by Volume (2012-2014)
The U.S. Constipation Market Volume by Type (2012-2014)
The U.S. Constipation Prescription Market by Drug Type (2015E)
The U.S. Amitiza Drug Market by Value (2015E-2020E)
The U.S. Plecanatide Drug Market by Value (2017E-2025E)
The U.S. Plecanatide Penetration Rate by Type (2017E-2025E)
Japan’s Constipation Market by Volume (2015E-2025E)
Japan’s Amitiza Drug Market Revenue and Penetration (2015E-2021E)
China’s Constipation Market by Volume (2015E-2025E)
The U.S. Chronic Constipation Market by Volume (2014-2025E)
European Chronic Constipation Market by Volume (2014-2025E)
The U.S. IBS-C Market by Volume (2014-2025E)
European IBS-C Market by Volume (2014-2025E)
The U.S. Opioid Induced Constipation Market by Volume (2015-2025E)
The U.S. Dolcanatide Market by Value (2019E-2025E)
European Opioid Induced Constipation Market by Volume (2015-2025E)
European Dolcanatide Market by Value (2020E-2027E)
Growing Prescription Opioid Drugs in the U.S. (2000-2014E)
Global Ageing Population Over 65 (2009-2014)
The U.S. Constipation Market by Branded/Non-Branded Therapy (2014)
The U.S. Constipation Market by Therapy (2015E-2020E)
Global Spending on Medicines (2010-2020E)
Global Female Population (2010-2014)
Global Healthcare Expenditure Per Capita (2009-2014E)
Global OTC Market CAGR Growth Rate (2011-2016)
Awareness of OIC Prescription Medications among Patients (2015)
Sucampo Revenue by Geographical Segments (2013/2014)
Sucampo Revenue and Net Income (2010-2014)
Synergy Pharmaceuticals Revenue and Net Income (2014-2018E)
Synergy’s Research and Development Expenditure (2011-2015)
AstraZeneca Revenue by Therapeutic Segment (2015)
AstraZeneca Revenue by Regions (2015)
AstraZeneca Revenue and Net profit (2010-2015)
Ironwood Pharmaceutical’s GI and Vascular/Fibrotic Platforms
Ironwood’s Revenue* and Net Loss (2011-2015)

List of Tables

Current Treatment Options for Constipation
Pipeline Drugs under Development for Constipation
Opportunity in Pediatric & Elderly Constipation
Global Constipation Competitors Comparison
Near-Term Clinical Pipelines of Sucampo
Synergy Pharmaceuticals Clinical-Stage Pipelines

For more Information:
http://www.konceptanalytics.com/Researchreport/global-constipation-market-report-2016-edition-3277.aspx

Koncept Analytics
Vikas Gupta
(Business Development Manager)
FFCS-36, Ansal Plaza
Vaishali, Ghaziabad
U.P - 201010
Tele: +91-120-4130959
Mobile: +91-9811715635
Mail ID – vikas@konceptanalytics.com

Koncept Analytics is a market research company. We are in the field of Market Research from last 10 Years. We do research in telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, food & beverages and media sectors. For more information:
http://www.konceptanalytics.com

Koncept Analytics
Vikas Gupta
(Business Development Manager)
http://www.konceptanalytics.com/Researchreport/global-constipation-market-report-2016-edition-3277.aspx

FFCS-36, Ansal Plaza
Vaishali, Ghaziabad
U.P - 201010
Tele: +91-120-4130959
Mobile: +91-9811715635
Mail ID – vikas@konceptanalytics.com

This release was published on openPR.